ARNT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.912200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.614600E-01
Normal-vs-Stage2
8.439900E-03
Normal-vs-Stage3
6.758900E-03
Normal-vs-Stage4
5.276400E-02
Stage1-vs-Stage2
3.170800E-01
Stage1-vs-Stage3
2.085600E-01
Stage1-vs-Stage4
3.410600E-01
Stage2-vs-Stage3
3.755900E-02
Stage2-vs-Stage4
9.565200E-01
Stage3-vs-Stage4
2.747000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.263800E-01
Normal-vs-AfricanAmerican
3.187400E-01
Normal-vs-Asian
4.847200E-04
Caucasian-vs-AfricanAmerican
5.877800E-01
Caucasian-vs-Asian
1.256150E-02
AfricanAmerican-vs-Asian
1.155230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.079600E-01
Normal-vs-Female
1.849200E-01
Male-vs-Female
7.967600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.675400E-01
Normal-vs-Age(41-60Yrs)
9.934300E-02
Normal-vs-Age(61-80Yrs)
2.335200E-01
Normal-vs-Age(81-100Yrs)
7.83960000000361E-05
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.974200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.881400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.903600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.349400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.784500E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.220300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.89950000000416E-05
Normal-vs-Daily Drinker
2.10109999999597E-05
Normal-vs-Weekly Drinker
1.235600E-03
Normal-vs-Occasional Drinker
5.804400E-01
Normal-vs-Social Drinker
5.828200E-01
Non Drinker-vs-Daily Drinker
5.517200E-01
Non Drinker-vs-Weekly Drinker
5.245800E-01
Non Drinker-vs-Occasional Drinker
1.395030E-01
Non Drinker-vs-Social Drinker
2.924100E-02
Daily Drinker-vs-Weekly Drinker
2.658600E-01
Daily Drinker-vs-Occasional Drinker
1.061590E-01
Daily Drinker-vs-Social Drinker
2.007800E-02
Weekly Drinker-vs-Occasional Drinker
2.045400E-01
Weekly Drinker-vs-Social Drinker
5.233600E-02
Occasional Drinker-vs-Social Drinker
7.714800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.203800E-01
Normal-vs-Grade 2
9.752400E-02
Normal-vs-Grade 3
2.535800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.940320E-02
Grade 1-vs-Grade 3
7.077700E-02
Grade 1-vs-Grade 4
3.203800E-01
Grade 2-vs-Grade 3
1.887960E-01
Grade 2-vs-Grade 4
9.752400E-02
Grade 3-vs-Grade 4
2.535800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.038160E-02
Normal-vs-NonDiabetic
2.691600E-01
Diabetic-vs-NonDiabetic
7.964000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.654400E-02
Normal-vs-NoPancreatitis
2.193800E-01
Pancreatitis-vs-NoPancreatitis
8.041600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.746600E-01
Normal-vs-N1
6.979500E-03
N0-vs-N1
4.817600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.081110E-03
Normal-vs-TP53-NonMutant
7.167200E-01
TP53-Mutant-vs-TP53-NonMutant
5.446100E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
